17 Hydroxyprogesterone measurement, serum

Van Vliet G & Czernichow P: Screening for neonatal endocrinopathies: rationale, methods and results. Semin Neonatol 2004; 9(1):75-85.

Olgemoller B, Roscher AA, Liebl B, et al: Screening for congenital adrenal hyperplasia: adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value. J Clin Endocrinol Metab 2003; 88:5790-5794.

Honour JW & Torresani T: Evaluation of neonatal screening for congenital adrenal hyperplasia. Horm Res 2001; 55(4):206-211.

Azziz R, Hincapie LA, Knochenhauer ES, et al: Screening for 21-hydrodylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study. Fertil Steril 1999; 72(5):915-925.